News & Analysis on Clinical Trial Services & Contract Research And Development
Celera Genomics announces its new test that is used for genotyping of the hepatitis C virus (HCV) has obtained regulatory approval for commercial sale in Europe, signifying the first real-time test for genotyping the HCV virus to receive the CE mark.
UK and Chinese R&D firms are this week being urged to band together to develop alternatives to the practice of using endangered animal parts to feed the vast traditional Chinese medicine industry.
BASF has unveiled new pharmaceutical auxiliaries which release active ingredients more quickly, particularly when it comes to small tablets.
Omnia Biologics has sealed a deal to help the Aeras Global TB Vaccine Foundation in its quest to make quantities of a new TB Vaccine that will "fulfil all the needs of the developing world."